At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
0.8% Hyaluronic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Laboratory Effect of 0.8% Hyaluronic Acid Gel in Conventional Treatment of Moderate to Severe Chronic Periodontitis
In Brief
A Phase 4 clinical trial evaluating 0.8% Hyaluronic Acid and Scaling and Root Planing for Periodontitis. Completed, enrolled 24 participants across 1 site.
Detailed Summary
assess the clinical and laboratory effects of the local and sub gingival application of a 0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in chronic moderate to severe periodontitis patients as indicated by expression of Human Beta Definsin-2 (HBD2) in gingival crevicular fluid (GCF).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontitis
CountriesSaudi Arabia
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
Primary CompletionAug 2017
Study CompletionOct 2017
First PostedOct 2017
TodayJul 2026
First PostedOct 17, 2017
Enrollment StartFeb 15, 2017
Primary CompletionAug 15, 2017
Study CompletionOct 2, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.7 years ago
Interventions
0.8% Hyaluronic Aciddrug
Application of 0.8% hyaluronic acid after scaling and root planing
Scaling and Root Planingprocedure
Scaling of the teeth using hand and ultrasonic scalers followed by planing of the root with curettes